In The News Posted May 6, 2022 Share Posted May 6, 2022 Management's assessment and value of Q BioMed outlined NEW YORK, May 6, 2022 /PRNewswire/ -- Q BioMed, Inc. (OTCQB: QBIO) a commercial-stage biotechnology development company outlines its strategy and value proposition for its stakeholders and shareholders. Q BioMed Inc. is a commercial...View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now